3,4-substituted pyrrolidine betasecretase inhibitors for the treatment of alzheimer's disease

Details for Australian Patent Application No. 2008339005 (hide)

International Classifications

Event Publications

10 June 2010 PCT application entered the National Phase

PCT publication WO2009/078932 Priority application(s): WO2009/078932

1 July 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Merck Sharp & Dohme Corp., Application No. 2008339005, under INID (54), correct the title to read 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of Alzheimer's disease

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.